# Blood Pressure Monitor(Model:Y30001) (Zhangzhou Easepal Medical Science and Technology Co., Ltd.)

Product · id `cardio:fdaprod-k213023` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [openFDA record K213023](<https://api.fda.gov/device/510k.json?search=k_number:K213023>), retrieved 8 November 2026. No person wrote or checked this page.

Browse, organ or system: Blood vessels  

## In plain language

A premarket notification (510(k)) in FDA's device records. FDA's decision is recorded as substantially equivalent (code SESE).

## Technical summary

510(k) K213023. Decision 2022-09-30 (code SESE). Product code DXN. Device class II.

## The registry's words

- 510(k) number: K213023
- Device name: Blood Pressure Monitor(Model:Y30001)
- Applicant: Zhangzhou Easepal Medical Science and Technology Co., Ltd.
- Product code: DXN
- Advisory committee: Cardiovascular
- Clearance type: Traditional

## Claims, with the population each applies to

## Context: FDA record read by the openFDA feed

Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)

### FDA records a clearance of K213023 on 2022-09-30.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved or cleared uses are in FDA's own decision documents, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: FDA 510(k) premarket notification K213023 (openFDA record) (Regulator) <https://api.fda.gov/device/510k.json?search=k_number:K213023>
     Locator: decision\_date. Retrieved 2026-11-08T02:46:29Z. Source state: Current. Version fingerprint: 0484eb39a6ea0983e075ccecefe57a7b17880011e206c3da33330f0d8038c94b.
     How it applies: The decision date as the record writes it.
  2. Supports: FDA 510(k) premarket notification K213023 (openFDA record) (Regulator) <https://api.fda.gov/device/510k.json?search=k_number:K213023>
     Locator: k\_number. Retrieved 2026-11-08T02:46:29Z. Source state: Current. Version fingerprint: 0484eb39a6ea0983e075ccecefe57a7b17880011e206c3da33330f0d8038c94b.
     How it applies: The registry number of the record.
  3. Supports: FDA 510(k) premarket notification K213023 (openFDA record) (Regulator) <https://api.fda.gov/device/510k.json?search=k_number:K213023>
     Locator: decision\_code. Retrieved 2026-11-08T02:46:29Z. Source state: Current. Version fingerprint: 0484eb39a6ea0983e075ccecefe57a7b17880011e206c3da33330f0d8038c94b.
     How it applies: The decision status as the record writes it.

## Guidance, authorization and access

### Regulatory decision `cardio:fdadec-k213023-clearance`

- Product: Blood Pressure Monitor(Model:Y30001) (Zhangzhou Easepal Medical Science and Technology Co., Ltd.) (`cardio:fdaprod-k213023`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Clearance, 2022-09-30
- Product version: Not stated in the openFDA record
- Pathway: 510(k)
- Submission: K213023
- Product code: DXN
- Device class: II
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-k213023-clearance`

## Provenance

Content hash: 5d371dd3117d2084d11209bbb06a72a5dc57285872f39c810146674a55c1a168
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
